The U.S. Department of Veterans Affairs has awarded a three-year contract to the American College of Radiology to serve as the accrediting organization for 33 VA hospital radiation oncology facilities across the country.
The U.S. Department of Veterans Affairs has awarded a three-year contract to the American College of Radiology to serve as the accrediting organization for 33 VA hospital radiation oncology facilities across the country.
The purpose of accreditation is to set quality practice standards and certify facilities that meet them, according to Dr. Harvey Neiman, ACR executive director. The peer-reviewed assessments include an evaluation of personnel qualifications, equipment performance, and image quality, as well as standards and protocols for quality assurance and quality control.
"The ACR is extremely proud to do its part to help ensure that our nation's veterans receive the highest quality healthcare available," Neiman said.
The college brings considerable experience to the assignment. About 200 radiation oncology facilities in the U.S. have either been accredited or are going through the ACR accreditation process. As with nongovernment facilities, the accreditation process for the VA services will involve both self-assessment and independent external expert audits, based on ACR guidelines and technical standards.
ACR accreditation requires that the physicians providing radiation therapy to patients meet specific education and training standards. It also mandates that the equipment be inspected regularly by qualified medical physicists and that the radiation therapists administering the treatments be appropriately certified.
In addition to radiation oncology, the ACR manages accreditation programs for MRI, CT, nuclear medicine, PET, diagnostic ultrasound, radiation oncology, stereotactic breast biopsy, mammography, and breast ultrasound. About 16,000 facilities have earned ACR accreditation, Neiman said.
For more information from the Diagnostic Imaging archives:
Proponents hail pass of Medicare bill as triumph for physicians, patients
FDA panel recommends adding stereotactic breast biopsy to quality standards program
Consultant describes how MRI services can meet accreditation deadline
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.